RedHill Biopharma Ltd. (RDHL) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    RedHill Biopharma Ltd.

    NASDAQ: RDHL · Real-Time Price · USD
    1.90
    -0.32 (-14.41%)
    At close: Oct 03, 2025, 3:59 PM
    1.95
    2.63%
    Pre-market: Oct 06, 2025, 04:04 AM EDT

    RedHill Biopharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -8.27M 23.92M -71.67M -97.74M
    Depreciation & Amortization
    		 619K 1.99M 8.15M 18.15M
    Stock-Based Compensation
    		 665K 1.65M 5.67M 10.21M
    Other Working Capital
    		 3.37M -50.44M 14.49M 10.04M
    Other Non-Cash Items
    		 -4.44M -47.79M 20.65M 5.37M
    Deferred Income Tax
    		 n/a n/a n/a 123K
    Change in Working Capital
    		 2.05M -15.58M 8.01M -1.15M
    Operating Cash Flow
    		 -9.37M -35.82M -29.18M -65.05M
    Capital Expenditures
    		 -9K -11K -198K -115K
    Cash Acquisitions
    		 n/a n/a n/a 8.03M
    Purchase of Investments
    		 n/a n/a n/a -8.5M
    Sales Maturities Of Investments
    		 n/a 14.96K 8.5M 475K
    Other Investing Acitivies
    		 n/a n/a n/a -8.03M
    Investing Cash Flow
    		 -9K 3.99K 8.3M -8.14M
    Debt Repayment
    		 -636K -1.18M -1.48M -1.68M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 790K 8.64M -10.88M -3.39M
    Financial Cash Flow
    		 8.42M 21.38M 11.45M 73.46M
    Net Cash Flow
    		 -952K -14.4M -9.51M 179K
    Free Cash Flow
    		 -9.38M -35.83M -29.38M -65.16M

    Add to Watchlist